Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Cash and Cash Equivalents, Period Increase (Decrease)

NIAGEN BIOSCIENCE, INC. Cash and Cash Equivalents, Period Increase (Decrease)

NIAGEN BIOSCIENCE, INC. (NAGE) reported Cash and Cash Equivalents, Period Increase (Decrease) of $27.99 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-06.

Discontinued › Cash Flow

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-05-06

  • NIAGEN BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-03-31 was $27.99M.
  • NIAGEN BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-12-31 was $1.22M.
  • NIAGEN BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-09-30 was -$3.41M.
  • NIAGEN BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-06-30 was $5.28M, a 1119.86% increase year-over-year.
  • NIAGEN BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for fiscal 2020 was -$2.12M.
  • NIAGEN BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$3.80M.
  • NIAGEN BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$22.77M, a 152.06% decline from fiscal 2017.
  • NIAGEN BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $43.75M.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 3 month as first filedCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 6 month as first filedCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 9 month as first filedCash and Cash Equivalents, Period Increase (Decrease) 12 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed
2021-03-31$27.99M
10-Q · filed 2021-05-06
$29.21M
derived: sum of 2 quarters · filed 2021-05-06
$25.80M
derived: sum of 3 quarters · filed 2021-05-06
$31.08M
derived: sum of 4 quarters · filed 2021-05-06
2020-12-31$1.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
-$2.19M
derived: sum of 2 quarters · filed 2021-03-12
$3.09M
derived: sum of 3 quarters · filed 2021-03-12
-$2.12M
10-K · filed 2021-03-12
2020-09-30-$3.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04
$1.87M
derived: sum of 2 quarters · filed 2020-11-04
-$3.33M
10-Q · filed 2020-11-04
-$3.40M
derived: sum of 4 quarters · filed 2021-05-06
2020-06-30$5.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$78.00K
10-Q · filed 2020-08-06
$11.00K
derived: sum of 3 quarters · filed 2021-05-06
-$870.00K
derived: sum of 4 quarters · filed 2021-05-06
2020-03-31-$5.20M
10-Q · filed 2021-05-06
-$5.27M
derived: sum of 2 quarters · filed 2021-05-06
-$6.15M
derived: sum of 3 quarters · filed 2021-05-06
-$5.72M
derived: sum of 4 quarters · filed 2021-05-06
2019-12-31-$67.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
-$948.00K
derived: sum of 2 quarters · filed 2021-03-12
-$515.00K
derived: sum of 3 quarters · filed 2021-03-12
-$3.80M
10-K · filed 2021-03-12
2019-09-30-$881.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04
-$448.00K
derived: sum of 2 quarters · filed 2020-11-04
-$3.74M
10-Q · filed 2020-11-04
-$9.34M
derived: sum of 4 quarters · filed 2020-11-04
2019-06-30$433.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$2.86M
10-Q · filed 2020-08-06
-$8.45M
derived: sum of 3 quarters · filed 2020-08-06
-$13.63M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31-$3.29M
10-Q · filed 2020-05-18
-$8.89M
derived: sum of 2 quarters · filed 2020-05-18
-$14.06M
derived: sum of 3 quarters · filed 2020-05-18
-$21.71M
derived: sum of 4 quarters · filed 2020-05-18
2018-12-31-$5.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
-$10.77M
derived: sum of 2 quarters · filed 2020-03-10
-$18.42M
derived: sum of 3 quarters · filed 2020-03-10
-$22.77M
10-K · filed 2020-03-10
2018-09-30-$5.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$12.82M
derived: sum of 2 quarters · filed 2019-11-12
-$17.18M
10-Q · filed 2019-11-12
$4.21M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30-$7.65M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
-$12.00M
10-Q · filed 2019-08-07
$9.39M
derived: sum of 3 quarters · filed 2019-08-07
$19.25M
derived: sum of 4 quarters · filed 2019-08-07
2018-03-31-$4.35M
10-Q · filed 2019-05-09
$17.04M
derived: sum of 2 quarters · filed 2019-05-09
$26.90M
derived: sum of 3 quarters · filed 2019-05-09
$39.85M
derived: sum of 4 quarters · filed 2019-05-09
2017-12-30$21.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
$31.25M
derived: sum of 2 quarters · filed 2019-03-07
$44.20M
derived: sum of 3 quarters · filed 2019-03-07
$43.75M
10-K · filed 2019-03-07
$43.75M
10-K · filed 2018-03-15
2017-09-30$9.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$22.82M
derived: sum of 2 quarters · filed 2018-11-07
$22.36M
10-Q · filed 2018-11-07
$22.36M
10-Q · filed 2017-11-09
$21.74M
derived: sum of 4 quarters · filed 2018-11-07
2017-07-01$12.95M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$12.50M
10-Q · filed 2018-08-09
$12.50M
10-Q · filed 2017-08-10
$11.87M
derived: sum of 3 quarters · filed 2018-08-09
$10.77M
derived: sum of 4 quarters · filed 2018-08-09
2017-04-01-$457.00K
10-Q · filed 2018-05-10
-$457.08K
10-Q · filed 2017-05-11
-$1.08M
derived: sum of 2 quarters · filed 2018-05-10
-$2.18M
derived: sum of 3 quarters · filed 2018-05-10
-$1.81M
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31-$622.33K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
-$1.73M
derived: sum of 2 quarters · filed 2018-03-15
-$1.35M
derived: sum of 3 quarters · filed 2018-03-15
-$3.91M
10-K · filed 2018-03-15
2016-10-01-$1.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
-$730.75K
derived: sum of 2 quarters · filed 2017-11-09
-$3.28M
10-Q · filed 2017-11-09
-$2.44M
derived: sum of 4 quarters · filed 2018-03-15
2016-07-02$374.71K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10
-$2.18M
10-Q · filed 2017-08-10
-$1.34M
derived: sum of 3 quarters · filed 2018-03-15
-$2.33M
derived: sum of 4 quarters · filed 2018-03-15
2016-04-02-$2.55M
10-Q · filed 2017-05-11
-$1.71M
derived: sum of 2 quarters · filed 2018-03-15
-$2.70M
derived: sum of 3 quarters · filed 2018-03-15
-$220.33K
derived: sum of 4 quarters · filed 2018-03-15
2016-01-02$841.03K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
-$149.58K
derived: sum of 2 quarters · filed 2018-03-15
$2.33M
derived: sum of 3 quarters · filed 2018-03-15
$1.58M
10-K · filed 2018-03-15
2015-10-03-$990.61K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$1.49M
derived: sum of 2 quarters · filed 2016-11-10
$743.89K
10-Q · filed 2016-11-10
$3.50M
derived: sum of 4 quarters · filed 2017-03-16
2015-07-04$2.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
$1.73M
10-Q · filed 2016-08-11
$4.50M
derived: sum of 3 quarters · filed 2017-03-16
$4.42M
derived: sum of 4 quarters · filed 2017-03-16
2015-04-04-$748.91K
10-Q · filed 2015-05-14
$2.01M
derived: sum of 2 quarters · filed 2017-03-16
$1.94M
derived: sum of 3 quarters · filed 2017-03-16
$1.29M
derived: sum of 4 quarters · filed 2017-03-16
2015-01-03$2.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$2.68M
derived: sum of 2 quarters · filed 2017-03-16
$2.04M
derived: sum of 3 quarters · filed 2017-03-16
$1.70M
10-K · filed 2017-03-16
2014-09-27-$76.87K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
-$720.78K
derived: sum of 2 quarters · filed 2015-11-12
-$1.06M
10-Q · filed 2015-11-12
$116.33K
derived: sum of 4 quarters · filed 2016-03-17
2014-06-28-$643.91K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
-$980.71K
10-Q · filed 2015-08-13
$193.20K
derived: sum of 3 quarters · filed 2016-03-17
$454.00K
derived: sum of 4 quarters · filed 2016-03-17
2014-03-29-$336.80K
10-Q · filed 2015-05-14
$837.11K
derived: sum of 2 quarters · filed 2016-03-17
$1.10M
derived: sum of 3 quarters · filed 2016-03-17
$957.96K
derived: sum of 4 quarters · filed 2016-03-17
2013-12-28$1.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-17
$1.43M
derived: sum of 2 quarters · filed 2016-03-17
$1.29M
derived: sum of 3 quarters · filed 2016-03-17
$1.74M
10-K · filed 2016-03-17
2013-09-28$260.79K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$120.85K
derived: sum of 2 quarters · filed 2014-11-06
$567.42K
10-Q · filed 2014-11-06
-$149.65K
derived: sum of 4 quarters · filed 2014-11-06
2013-06-29-$139.94K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
$306.63K
10-Q · filed 2014-08-12
-$410.44K
derived: sum of 3 quarters · filed 2014-08-12
-$1.39M
derived: sum of 4 quarters · filed 2014-08-12
2013-03-30$446.58K
10-Q · filed 2014-05-08
-$270.50K
derived: sum of 2 quarters · filed 2014-05-08
-$1.25M
derived: sum of 3 quarters · filed 2014-05-08
-$4.84M
derived: sum of 4 quarters · filed 2014-05-08
2012-12-29-$717.07K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27
-$1.69M
derived: sum of 2 quarters · filed 2014-03-27
-$5.29M
derived: sum of 3 quarters · filed 2014-03-27
$99.85K
10-K · filed 2014-03-27
2012-09-29-$975.94K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-21
-$4.57M
derived: sum of 2 quarters · filed 2013-12-05
$816.92K
10-Q · filed 2013-11-21
-$832.24K
derived: sum of 4 quarters · filed 2013-12-05
2012-06-30-$3.59M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-12-05
$1.79M
10-Q/A · filed 2013-12-05
$143.70K
derived: sum of 3 quarters · filed 2013-12-05
$168.16K
derived: sum of 4 quarters · filed 2013-12-05
2012-03-31$5.39M
10-Q/A · filed 2013-12-05
$3.74M
derived: sum of 2 quarters · filed 2013-12-05
$3.76M
derived: sum of 3 quarters · filed 2013-12-05
$2.91M
derived: sum of 4 quarters · filed 2013-12-05
2011-12-31-$1.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29
-$1.62M
derived: sum of 2 quarters · filed 2013-03-29
-$2.48M
derived: sum of 3 quarters · filed 2013-03-29
-$1.81M
10-K · filed 2013-03-29
2011-10-01$24.46K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
-$826.47K
derived: sum of 2 quarters · filed 2012-11-08
-$157.15K
10-Q · filed 2012-11-08
-$916.32K
derived: sum of 4 quarters · filed 2012-11-08
2011-07-02-$850.93K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-10
-$181.61K
10-Q/A · filed 2012-08-10
-$940.78K
derived: sum of 3 quarters · filed 2012-08-10
-$1.34M
derived: sum of 4 quarters · filed 2012-08-10
2011-04-02$669.32K
10-Q · filed 2012-05-10
-$89.86K
derived: sum of 2 quarters · filed 2012-05-10
-$485.97K
derived: sum of 3 quarters · filed 2012-05-10
2011-01-01-$759.17K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15
-$1.16M
derived: sum of 2 quarters · filed 2012-03-15
$1.76M
10-K · filed 2012-03-15
2010-10-02-$396.11K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10
$2.51M
10-Q · filed 2011-11-10
2010-07-03$2.91M
10-Q · filed 2011-08-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87